4//SEC Filing
VASCONCELLES MICHAEL 4
Accession 0000899243-22-028910
CIK 0001690585other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 8:19 AM ET
Size
5.4 KB
Accession
0000899243-22-028910
Insider Transaction Report
Form 4
VASCONCELLES MICHAEL
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-08-15+40,000→ 40,000 totalExercise: $1.77Exp: 2032-08-14→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over three years, with 33% of this option vesting on August 15, 2023, and the remainder vesting in 24 equal monthly installments thereafter.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001734755
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 8:19 AM ET
- Size
- 5.4 KB